It was a pleasure for Protavio to participate in xMAP® Connect 2024, held in Amsterdam on November 12-13. As a trusted partner in the Luminex multiplexing community, we participate in this annual event that offers a dynamic platform for xMAP technology experts from industry and academia to share the latest advancements in multiplex assay technology.
At this year’s event, Protavio proudly showcased our robust capabilities in Luminex assay development and GMP manufacturing. Visitors to our booth had the opportunity to explore how xMAP technology enables the development of custom multiplex assays, optimized for clinical applications. Through the xMAP® technology platform, we empower researchers and clinicians with the tools to accelerate discovery, enhance diagnostic accuracy, and support cutting-edge quality control measures in a variety of applications.
The two-day event featured an exciting agenda, including expert presentations that highlighted the versatility of xMAP® technology in addressing diverse scientific and clinical challenges. We were inspired by the exchange of ideas and the collaborations formed with like-minded professionals who share a passion for advancing multiplexing technologies.
Protavio extends heartfelt thanks to all attendees who visited our booth and engaged with our team to learn more about our solutions that span from biomarker discovery and validation to GMP manufacturing of in vitro diagnostics, ensuring the highest levels of precision and quality.
We are also deeply grateful to Luminex for organizing such a well-rounded and impactful event, fostering innovation and collaboration across the multiplexing community.